US Stock MarketDetailed Quotes

PCSA Processa Pharmaceuticals

Watchlist
  • 0.9780
  • +0.1179+13.71%
Close Nov 25 16:00 ET
  • 1.0200
  • +0.0420+4.29%
Post 17:41 ET
3.20MMarket Cap-203P/E (TTM)

Processa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
58.00%3.42M
13.54%3.08M
-31.57%2.81M
-43.44%11.46M
-57.42%2.47M
-64.21%2.17M
-47.51%2.71M
27.16%4.11M
75.13%20.26M
72.15%5.8M
Selling and administrative expenses
11.96%1.14M
31.69%1.35M
-48.73%1.27M
-35.44%5.66M
-56.25%1.15M
-65.21%1.02M
-49.55%1.03M
109.17%2.48M
86.89%8.76M
102.29%2.63M
-General and administrative expense
11.96%1.14M
31.69%1.35M
-48.73%1.27M
-35.44%5.66M
-56.25%1.15M
-65.21%1.02M
-49.55%1.03M
109.17%2.48M
86.89%8.76M
102.29%2.63M
Research and development costs
98.61%2.29M
2.50%1.73M
-5.43%1.54M
-49.54%5.8M
-58.39%1.32M
-63.28%1.15M
-46.19%1.69M
-20.38%1.63M
67.12%11.49M
53.26%3.17M
Operating profit
-58.00%-3.42M
-13.54%-3.08M
31.57%-2.81M
43.44%-11.46M
57.42%-2.47M
64.21%-2.17M
47.51%-2.71M
-27.16%-4.11M
-75.13%-20.26M
-72.15%-5.8M
Net non-operating interest income expense
-53.13%40.15K
-0.29%83.22K
231.56%335.54K
16.19%64.52K
133.36%85.66K
5,172.39%83.46K
770.41%101.2K
1,503.06%55.53K
Non-operating interest income
-53.13%40.15K
----
-0.29%83.22K
231.56%335.54K
16.19%64.52K
133.36%85.66K
----
5,172.39%83.46K
770.41%101.2K
1,503.06%55.53K
Other net income (expense)
-29.64%71.7K
101.9K
-1,704.35%-7.27M
Special income (charges)
----
----
----
--0
----
----
----
----
-1,704.35%-7.27M
----
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--7.27M
----
Other non- operating income (expenses)
----
-29.64%71.7K
----
----
----
----
--101.9K
----
----
----
Income before tax
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
59.45%-11.12M
81.52%-2.4M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-129.34%-27.42M
-286.63%-13.01M
Income tax
0
0
0
0
Net income
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
59.45%-11.12M
81.52%-2.4M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-139.98%-27.42M
-308.70%-13.01M
Net income continuous Operations
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
59.45%-11.12M
81.52%-2.4M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-139.98%-27.42M
-308.70%-13.01M
Minority interest income
Net income attributable to the parent company
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
59.45%-11.12M
81.52%-2.4M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-139.98%-27.42M
-308.70%-13.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
59.45%-11.12M
81.52%-2.4M
65.42%-2.08M
49.41%-2.61M
-24.63%-4.02M
-139.98%-27.42M
-308.70%-13.01M
Basic earnings per share
33.12%-1.03
47.94%-1.01
68.56%-1.11
75.10%-8.48
89.60%-1.67
79.19%-1.54
69.69%-1.94
11.75%-3.53
-127.00%-34.05
-282.14%-16.05
Diluted earnings per share
33.12%-1.03
47.94%-1.01
68.56%-1.11
75.10%-8.48
89.60%-1.67
79.19%-1.54
69.69%-1.94
11.75%-3.53
-127.00%-34.05
-282.14%-16.05
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 58.00%3.42M13.54%3.08M-31.57%2.81M-43.44%11.46M-57.42%2.47M-64.21%2.17M-47.51%2.71M27.16%4.11M75.13%20.26M72.15%5.8M
Selling and administrative expenses 11.96%1.14M31.69%1.35M-48.73%1.27M-35.44%5.66M-56.25%1.15M-65.21%1.02M-49.55%1.03M109.17%2.48M86.89%8.76M102.29%2.63M
-General and administrative expense 11.96%1.14M31.69%1.35M-48.73%1.27M-35.44%5.66M-56.25%1.15M-65.21%1.02M-49.55%1.03M109.17%2.48M86.89%8.76M102.29%2.63M
Research and development costs 98.61%2.29M2.50%1.73M-5.43%1.54M-49.54%5.8M-58.39%1.32M-63.28%1.15M-46.19%1.69M-20.38%1.63M67.12%11.49M53.26%3.17M
Operating profit -58.00%-3.42M-13.54%-3.08M31.57%-2.81M43.44%-11.46M57.42%-2.47M64.21%-2.17M47.51%-2.71M-27.16%-4.11M-75.13%-20.26M-72.15%-5.8M
Net non-operating interest income expense -53.13%40.15K-0.29%83.22K231.56%335.54K16.19%64.52K133.36%85.66K5,172.39%83.46K770.41%101.2K1,503.06%55.53K
Non-operating interest income -53.13%40.15K-----0.29%83.22K231.56%335.54K16.19%64.52K133.36%85.66K----5,172.39%83.46K770.41%101.2K1,503.06%55.53K
Other net income (expense) -29.64%71.7K101.9K-1,704.35%-7.27M
Special income (charges) --------------0-----------------1,704.35%-7.27M----
-Less:Impairment of capital assets --------------0------------------7.27M----
Other non- operating income (expenses) -----29.64%71.7K------------------101.9K------------
Income before tax -62.57%-3.38M-15.22%-3.01M32.21%-2.73M59.45%-11.12M81.52%-2.4M65.42%-2.08M49.41%-2.61M-24.63%-4.02M-129.34%-27.42M-286.63%-13.01M
Income tax 0000
Net income -62.57%-3.38M-15.22%-3.01M32.21%-2.73M59.45%-11.12M81.52%-2.4M65.42%-2.08M49.41%-2.61M-24.63%-4.02M-139.98%-27.42M-308.70%-13.01M
Net income continuous Operations -62.57%-3.38M-15.22%-3.01M32.21%-2.73M59.45%-11.12M81.52%-2.4M65.42%-2.08M49.41%-2.61M-24.63%-4.02M-139.98%-27.42M-308.70%-13.01M
Minority interest income
Net income attributable to the parent company -62.57%-3.38M-15.22%-3.01M32.21%-2.73M59.45%-11.12M81.52%-2.4M65.42%-2.08M49.41%-2.61M-24.63%-4.02M-139.98%-27.42M-308.70%-13.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -62.57%-3.38M-15.22%-3.01M32.21%-2.73M59.45%-11.12M81.52%-2.4M65.42%-2.08M49.41%-2.61M-24.63%-4.02M-139.98%-27.42M-308.70%-13.01M
Basic earnings per share 33.12%-1.0347.94%-1.0168.56%-1.1175.10%-8.4889.60%-1.6779.19%-1.5469.69%-1.9411.75%-3.53-127.00%-34.05-282.14%-16.05
Diluted earnings per share 33.12%-1.0347.94%-1.0168.56%-1.1175.10%-8.4889.60%-1.6779.19%-1.5469.69%-1.9411.75%-3.53-127.00%-34.05-282.14%-16.05
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data